During the past decade, Nanbu-Tokushukai Hospital conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Nanbu-Tokushukai Hospital" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Kagoshima University" with 1 trials as a collaborator, "Moji Medical Center, Kyusyu Rosai Hospital" with 1 trials as a collaborator and "Nippon Medical School" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Nanbu-Tokushukai Hospital" are "Heart Failure" (2 trials), "Stroke" (2 trials), "Invasive Extraintestinal Pathogenic Escherichia Coli Disease (IED) Prevention" (1 trials) and "Respiratory Syncytial Virus Prevention" (1 trials). Many other conditions were trialed in "Nanbu-Tokushukai Hospital" in a lesser frequency.

Most popular intervention types in "Nanbu-Tokushukai Hospital" are "Other" (4 trials), "Biological" (2 trials), "Device" (2 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Empagliflozin" (2 trials), "Ad26/protein preF RSV Vaccine" (1 trials), "Control" (1 trials) and "ExPEC9V" (1 trials). Other intervention names were less common.

The vast majority of trials in "Nanbu-Tokushukai Hospital" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Nanbu-Tokushukai Hospital". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Nanbu-Tokushukai Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Nanbu-Tokushukai Hospital, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".